Anaheim, Calif.—In the 1980s, up to 70% of cancer patients reported pain. Thirty years later, cancer pain prevalence has not changed noticeably, reported Julie Waldfogel, PharmD, at the 2017 annual meeting of the Hematology/Oncology Pharmacy Association.
“We haven’t gotten where we want to be yet,” said Dr. Waldfogel, a clinical pharmacy specialist in pain and palliative care at the Johns Hopkins Hospital in Baltimore.
The problem is there are many barriers to optimum